Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale SVP, FINANCE AND CAO sold 3,925 shares at $1.11 ($4,357)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 92,233 shares at an average $1.08 ($99,352)
  9. 4 Open-market buy Chief Financial Officer bought 75,000 shares at $0.78 ($58,403)
  10. 4 Open-market sale SVP, FINANCE AND CAO sold 611 shares at $0.64 ($391)
  11. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,382 shares at $0.64 ($1,525)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale SVP, FINANCE AND CAO sold 2,011 shares at $0.45 ($905)
  15. 4 Open-market sale SVP, FINANCE AND CAO sold 1,532 shares at $0.43 ($659)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award SVP, FINANCE AND CAO acquired 3,000 shares (grant or award)

Page 2 of 11 · 213 filings